Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630

The proliferative effect of adjuvant tamoxifen on the endometrium can potentially result in endometrial abnormalities, including cancer in postmenopausal women. We conducted a randomized, controlled trial to assess endometrial pathological diagnoses in postmenopausal women with early stage, ER-posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Potkul, Ronald K, Unger, Joseph M, Livingston, Robert B, Crew, Katherine D, Wilczynski, Sharon P, Salomon, Caryl G, Smith, Barbara L, Wong, Lucas, Campbell, David L, Einspahr, David E, Anderson, Garnet L, Hershman, Dawn, Goodman, Gary E, Brown, Powel H, Meyskens, Frank L, Albain, Kathy S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515330/
https://www.ncbi.nlm.nih.gov/pubmed/28721383
http://dx.doi.org/10.1038/npjbcancer.2016.24

Ejemplares similares

Ejemplares similares